ScholarIQanswers from OpenAlex

A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells

PaperCitations, authors & open-access status

A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells have?

ScholarIQcitation count

A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells has 265 citations in the OpenAlex counts ScholarIQ stores.

When was A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells published?

ScholarIQyear

A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells has 1995 year in the ScholarIQ index.

What is the open-access status of A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells?

ScholarIQoa status

A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells has hybrid oa status in the ScholarIQ index.

What is the DOI of A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells?

ScholarIQdoi

The DOI for A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells is on the source record.

What is the PMID of A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells?

ScholarIQpmid

The PMID for A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells is on the source record.

What is the OpenAlex record for A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells?

ScholarIQopenalex

The OpenAlex for A Novel ATP-dependent Inward Rectifier Potassium Channel Expressed Predominantly in Glial Cells is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial